The following on the treatments of adenocarcinomas in Barrett's esophagus contains commentaries on endo mucosal resection; choice between other ablative therapies; the remaining genetic abnormalities following stepwise endoscopic mucosal resection and possible recurrences; the Fotelo-Fotesi PDT; the CT TNM classification of early stages of Barrett's carcinoma; the indications of lymphadenectomy in intramucosal cancer; the differences in lymph node yield in transthoracic versus transhiatal dissection; video-assisted lymphadenectomy; and the importance of the length of proximal esophageal resectipon; and indications of sentinel node dissection.

, , , , , , , , , , , , , , , , , , , , , , , , , , ,
doi.org/10.1111/j.1749-6632.2011.06055.x, hdl.handle.net/1765/30832
New York Academy of Sciences. Annals
Erasmus MC: University Medical Center Rotterdam

Komanduri, S, Deprez, P.H, Atasoy, A, Hofmann, G, Pokieser, P, Ba-Ssalamah, A, … Stein, H. (2011). Barrett's esophagus: Treatments of adenocarcinomas I. New York Academy of Sciences. Annals, 1232(1), 248–264. doi:10.1111/j.1749-6632.2011.06055.x